Why Big Pharma Ignores Rare Diseases (It’s All About Profits)

The first episode of DeSci Pilled explores the future of decentralized science and its potential to transform biotech and rare disease research. Host Ryan Bethencourt speaks with Ethan Perlstein, a scientist and biotech entrepreneur, about how blockchain, DAOs, and decentralized funding are reshaping medicine.